Carregant...

Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers

The development of new therapeutics for the treatment of neurodegenerative pathophysiologies currently stands at a crossroads. This presents an opportunity to transition future drug discovery efforts to target disease modification, an area in which much still remains unknown. In this Perspective we...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Trippier, Paul C., Labby, Kristin Jansen, Hawker, Dustin D., Mataka, Jan J., Silverman, Richard B.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637880/
https://ncbi.nlm.nih.gov/pubmed/23458846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm3015926
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!